120 related articles for article (PubMed ID: 38328848)
21. Study on the relationship between miR-520g and the development of breast cancer.
Ren GB; Wang L; Zhang FH; Meng XR; Mao ZP
Eur Rev Med Pharmacol Sci; 2016; 20(4):657-63. PubMed ID: 26957267
[TBL] [Abstract][Full Text] [Related]
22. Increased expression of miR-330-3p: a novel independent indicator of poor prognosis in human breast cancer.
Wang H; Chen SH; Kong P; Zhang LY; Zhang LL; Zhang NQ; Gu H
Eur Rev Med Pharmacol Sci; 2018 Mar; 22(6):1726-1730. PubMed ID: 29630118
[TBL] [Abstract][Full Text] [Related]
23. Expression and prognostic value of miRNA-29b in peripheral blood for endometrial cancer.
Wang H; Wang TT; Lv XP
Future Oncol; 2018 Jun; 14(14):1365-1376. PubMed ID: 29848072
[TBL] [Abstract][Full Text] [Related]
24. MiR-34b is associated with clinical outcome in triple-negative breast cancer patients.
Svoboda M; Sana J; Redova M; Navratil J; Palacova M; Fabian P; Slaby O; Vyzula R
Diagn Pathol; 2012 Mar; 7():31. PubMed ID: 22439831
[TBL] [Abstract][Full Text] [Related]
25. Prognostic value of the microRNA-29 family in patients with primary osteosarcomas.
Hong Q; Fang J; Pang Y; Zheng J
Med Oncol; 2014 Aug; 31(8):37. PubMed ID: 25015394
[TBL] [Abstract][Full Text] [Related]
26. The diagnostic role of microRNA-34a in breast cancer: a systematic review and meta-analysis.
Imani S; Zhang X; Hosseinifard H; Fu S; Fu J
Oncotarget; 2017 Apr; 8(14):23177-23187. PubMed ID: 28423566
[TBL] [Abstract][Full Text] [Related]
27. miR-27a regulates the sensitivity of breast cancer cells to cisplatin treatment via BAK-SMAC/DIABLO-XIAP axis.
Zhou S; Huang Q; Zheng S; Lin K; You J; Zhang X
Tumour Biol; 2016 May; 37(5):6837-45. PubMed ID: 26662313
[TBL] [Abstract][Full Text] [Related]
28. Prognostic and biological significance of microRNA-221 in breast cancer.
Eissa S; Matboli M; Sharawy A; El-Sharkawi F
Gene; 2015 Dec; 574(1):163-7. PubMed ID: 26253160
[TBL] [Abstract][Full Text] [Related]
29. Inverse correlation of miR-27a-3p and CDH5 expression serves as a diagnostic biomarker of proliferation and metastasis of clear cell renal carcinoma.
Wang Y; Zhou X; Han P; Lu Y; Zhong X; Yang Y; Li D; Liu D; Li Q; Pan N; Mo Y; Luo W; Li P; Zhou X; Liudmila M
Pathol Res Pract; 2021 Apr; 220():153393. PubMed ID: 33740544
[TBL] [Abstract][Full Text] [Related]
30. Identification of miRNA-Based Signature as a Novel Potential Prognostic Biomarker in Patients with Breast Cancer.
Tang J; Ma W; Zeng Q; Tan J; Cao K; Luo L
Dis Markers; 2019; 2019():3815952. PubMed ID: 31976020
[TBL] [Abstract][Full Text] [Related]
31. Expression level of human miR-34a correlates with glioma grade and prognosis.
Gao H; Zhao H; Xiang W
J Neurooncol; 2013 Jun; 113(2):221-8. PubMed ID: 23529798
[TBL] [Abstract][Full Text] [Related]
32. Increased Expression of MiR-27a and MiR-24-2 in Esophageal Squamous Cell Carcinoma.
Maghsudlu M; Farashahi Yazd E; Amiriani T
J Gastrointest Cancer; 2020 Mar; 51(1):227-233. PubMed ID: 31020570
[TBL] [Abstract][Full Text] [Related]
33. DSCAM-AS1 promotes tumor growth of breast cancer by reducing miR-204-5p and up-regulating RRM2.
Liang WH; Li N; Yuan ZQ; Qian XL; Wang ZH
Mol Carcinog; 2019 Apr; 58(4):461-473. PubMed ID: 30457164
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA expressions in HPV-induced cervical dysplasia and cancer.
Gocze K; Gombos K; Kovacs K; Juhasz K; Gocze P; Kiss I
Anticancer Res; 2015 Jan; 35(1):523-30. PubMed ID: 25550598
[TBL] [Abstract][Full Text] [Related]
35. Feasibility of urinary microRNA detection in breast cancer patients and its potential as an innovative non-invasive biomarker.
Erbes T; Hirschfeld M; Rücker G; Jaeger M; Boas J; Iborra S; Mayer S; Gitsch G; Stickeler E
BMC Cancer; 2015 Mar; 15():193. PubMed ID: 25886191
[TBL] [Abstract][Full Text] [Related]
36. Expression analysis of three miRNAs, miR-26a, miR-29b and miR-519d, in relation to MMP-2 expression level in non-small cell lung cancer patients: a pilot study.
Pastuszak-Lewandoska D; Kordiak J; Czarnecka KH; Migdalska-Sęk M; Nawrot E; Domańska-Senderowska D; Kiszałkiewicz JM; Antczak A; Górski P; Brzeziańska-Lasota E
Med Oncol; 2016 Aug; 33(8):96. PubMed ID: 27447710
[TBL] [Abstract][Full Text] [Related]
37. MicroRNA-34a targets epithelial to mesenchymal transition-inducing transcription factors (EMT-TFs) and inhibits breast cancer cell migration and invasion.
Imani S; Wei C; Cheng J; Khan MA; Fu S; Yang L; Tania M; Zhang X; Xiao X; Zhang X; Fu J
Oncotarget; 2017 Mar; 8(13):21362-21379. PubMed ID: 28423483
[TBL] [Abstract][Full Text] [Related]
38. Circular RNA 0007255 regulates the progression of breast cancer through miR-335-5p/SIX2 axis.
Jia Q; Ye L; Xu S; Xiao H; Xu S; Shi Z; Li J; Chen Z
Thorac Cancer; 2020 Mar; 11(3):619-630. PubMed ID: 31962380
[TBL] [Abstract][Full Text] [Related]
39. Prognostic and biological significance of microRNA-127 expression in human breast cancer.
Wang S; Li H; Wang J; Wang D; Yao A; Li Q
Dis Markers; 2014; 2014():401986. PubMed ID: 25477702
[TBL] [Abstract][Full Text] [Related]
40. MiR-34a expression has an effect for lower risk of metastasis and associates with expression patterns predicting clinical outcome in breast cancer.
Peurala H; Greco D; Heikkinen T; Kaur S; Bartkova J; Jamshidi M; Aittomäki K; Heikkilä P; Bartek J; Blomqvist C; Bützow R; Nevanlinna H
PLoS One; 2011; 6(11):e26122. PubMed ID: 22102859
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
